Posted by Michael Wonder on 17 Mar 2023
Government maintains access to fast acting insulin
17 March 2023 - The Albanese Government has secured access to Fiasp and Fiasp FlexTouch on the PBS for Australians living with type 1 diabetes for the next six months.
The decision comes after the sponsor of the drug, Novo Nordisk, decided to remove Fiasp from the PBS for commercial reasons on 1 April 2023.
Under the Supply Only arrangements to be implemented by the Government from 1 April 2023, patients who already have a prescription will be able to refill their current scripts and repeat scripts at a pharmacy over the next six months.
